Skip to main content
. Author manuscript; available in PMC: 2013 Nov 18.
Published in final edited form as: Naunyn Schmiedebergs Arch Pharmacol. 2012 Jan 17;385(5):10.1007/s00210-011-0719-6. doi: 10.1007/s00210-011-0719-6

Figure 3.

Figure 3

Inhibition of adenylyl cyclase activity via stimulation of A1 receptors. Adenylyl cyclase was stimulated with forskolin (F) and concentration-dependent inhibition by fludarabine, clofarabine and cladribine is shown. The maximal inhibition is comparable to the full A1 receptor agonist CCPA. Data represent percent of forskolin-stimulated cyclase activity over basal (n = 3, error bars show SEM).